华海药业：卡格列净片获得药品注册证书

Core Viewpoint - Huahai Pharmaceutical has received approval from the National Medical Products Administration for the registration certificate of Canagliflozin tablets, which can be used in combination with Metformin and Sulfonylureas to improve blood sugar control in adults with type 2 diabetes [1] Company Summary - The approved Canagliflozin tablets can be used alone or in combination with Metformin when blood sugar control is inadequate with Metformin alone [1] - The product can also be used in conjunction with Metformin and Sulfonylureas when blood sugar control remains inadequate with the combination of Metformin and Sulfonylureas [1] Industry Summary - The approval of Canagliflozin tablets highlights the ongoing development and regulatory progress in the diabetes treatment sector, particularly for type 2 diabetes management [1]